Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2025 16:52 ET | Source: Robbins LLP

SVRA Lead Plaintiff Deadline (11/7/25) Reminder: Savara Inc. Investors Should Contact Robbins LLP for Information About the Class Action Lawsuit

Savara stock declined 31.7% after the FDA declined to file its MOLBREEVI application, citing incomplete chemistry, manufacturing, and controls information.
September 12, 2025 16:01 ET | Source: Robbins LLP

SVRA Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Savara Inc. Securities Class Action Lawsuit

Robbins LLP is Investigating Allegations that Savara Inc. (SVRA) Misled Investors About the Viability of its Lead Drug Candidate
September 09, 2025 19:24 ET | Source: Robbins LLP

SVRA Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Savara Inc.

Robbins LLP is Investigating Allegations that Savara Inc. (SVRA) Misled Investors About the Viability of its Lead Drug Candidate